SenesTech Reports Record Q3 2026 Revenue with 59% Year-Over-Year Growth

Revenue growth and lower quarterly operating cash use accompanied a wider net loss and additional share-sale funding.

Rhea-AI Summary

SenesTech (SNES) reported record third-quarter 2026 revenue of $1.097 million, its first quarter above the million-dollar mark. Revenue rose 59% year over year and 42% from Q2. E-commerce accounted for approximately 71% of revenue, while subscription revenue increased 53% sequentially. Gross profit reached $796,000; gross margin was 72.6%, versus 73.6% in Q2 and 62.8% a year earlier.

Net loss widened to $1.956 million from $1.298 million a year earlier, and loss per share increased to $0.36 from $0.28. Quarterly operating cash use declined to $1.322 million from $1.379 million a year earlier. Cash ended September at $3.951 million, versus $7.575 million at year-end 2025. After quarter-end, SenesTech raised $1.2 million in gross proceeds through its at-the-market share-sale program. The company expanded its B2B sales team and expects newly launched assessment services to provide an additional revenue opportunity.

15 points · 1 major

MixediHow this balance works

How this balance works

Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.

It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.

Rhea-AI Sentiment measures something else, the tone of the wording.

How the balance worksHow Sentiment works

2 major · 12 points

Hollow bars mark forward-looking points. How the balance works

Positive

• Major pointPost-quarter share sales raised $1.2 million in gross proceeds through the at-the-market program. 19% of market cap
• Moderate pointQ3 revenue of $1.097 million rose 59% year over year and 42% sequentially, setting a record.
• Moderate pointQ3 gross profit of $796,000 rose 40% sequentially and 84% year over year, setting a record.
• Moderate pointQ3 operating cash use fell to $1.322 million from $1.379 million a year earlier.
• Minor pointNine-month revenue increased to $2.360 million from $1.800 million in 2025.

10 minor points

• Minor pointE-commerce revenue increased 52% sequentially and 337% year over year, reaching approximately 71% of Q3 revenue.
• Minor pointSubscription revenue increased 53% sequentially and 234% year over year in Q3.
• Minor pointCombined Amazon and website subscribers increased 72% compared with Q2 2026.
• Minor pointDirect B2B revenue increased 19% sequentially and 2% year over year in Q3.
• Minor pointEvolve revenue increased 67% year over year to $979,000, representing 89% of Q3 product revenue.
• Minor pointContraPest revenue increased 13% year over year to $118,000, driven by higher refill sales.
• Minor pointNine-month gross profit increased to $1.701 million from $1.155 million in 2025.
• Minor point. Forward-looking: it has not happened yet and may not happen.B2B sales capacity expanded by two salespeople to four; two additional hires are expected by year-end.
• Minor point. Forward-looking: it has not happened yet and may not happen.Assessment services launched in July are expected by SenesTech to provide an additional revenue opportunity.
• Minor pointNine-month research and development expense declined to $1.217 million from $1.245 million in 2025.

Negative

• Major pointQ3 net loss widened to $1.956 million from $1.298 million; loss per share rose to $0.36 from $0.28.
• Major pointAt-the-market share issuance adds dilution alongside the $1.2 million in gross proceeds raised after quarter-end. 19% of market cap
• Moderate pointCash and cash equivalents fell to $3.951 million at September 30 from $7.575 million at year-end 2025.
• Moderate pointStockholders’ equity declined to $4.598 million at September 30 from $9.568 million at year-end 2025.
• Minor pointNine-month net loss widened to $5.851 million from $4.579 million, although loss per share narrowed to $1.10 from $1.75.

7 minor points

• Minor pointQ3 gross margin of 72.6% fell from 73.6% sequentially, although above 62.8% a year earlier.
• Minor pointQ3 adjusted EBITDA loss, a non-GAAP operating measure, widened to $1.428 million from $1.140 million a year earlier.
• Minor pointNine-month adjusted EBITDA loss widened to $4.379 million from $3.752 million in 2025.
• Minor pointSales and marketing expense rose to $1.082 million in Q3 from $425,000 a year earlier.
• Minor pointGeneral and administrative expense rose to $1.287 million in Q3 from $955,000 a year earlier.
• Minor pointQ3 research and development expense increased to $418,000 from $400,000 a year earlier.
• Minor pointNine-month operating cash use increased to $4.960 million from $4.086 million in 2025.

Argus 15 min delay 12 alerts

-7.76% vs previous close $0.9501 last price 0.3x rel. volume Open Argus

Details

Market move: SNES -7.76% vs previous close. Q3 2026 earnings report

-30.8% Trough in 3 min

$0.76 – $1.17 Day Range

$5.15M Mkt Cap at Last Price

On Nov 10, the day this news came out, the latest delayed price for SNES is 7.76% below the previous close. Argus tracked a trough of -30.8% from its starting point during tracking. Our momentum scanner has recorded 12 alerts for this stock so far that day. The latest delayed price is $0.95.

Data tracked by StockTitan Argus (15 min delayed). Upgrade to Gold for real-time data.

Key Figures

Q3 revenue: $1.097 million Year-over-year revenue growth: 59% E-commerce revenue growth: 337% +5 more

Q3 revenue

$1.097 million

Q3 2026

Year-over-year revenue growth

59%

Q3 2026 versus Q3 2025

E-commerce revenue growth

337%

Year over year in Q3 2026

Gross profit

$796,000

Record Q3 2026 result

Gross margin

72.6%

Q3 2026; 73.6% in Q2 2026 and 62.8% in Q3 2025

Net loss

$1.956 million

Q3 2026; $1.298 million in Q3 2025

Cash and cash equivalents

$3.951 million

At September 30, 2026

ATM proceeds

$1.2 million gross

Raised subsequent to quarter-end

Historical Context

1 past event · Latest: Oct 22

1 event

1. Oct 22

   Preliminary revenue

   24h Move

   +6.5%

   Preliminary Q3 revenue was approximately $1.1 million, alongside a Nasdaq minimum-bid-price notice.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

non-gaap, integrated pest management

2 terms

non-gaap financial

"Adjusted EBITDA is a non-GAAP measure"

Non-GAAP refers to financial measures that companies use to show their earnings or performance without including certain expenses or income that are often added back to give a different picture. It matters because it can make a company's results look better or more favorable, but it may also hide important costs, so investors need to look at both GAAP (official rules) and non-GAAP numbers to get a full understanding.

View in glossary

integrated pest management technical

"as part of an integrated pest management (IPM) program"

Integrated pest management is an approach to controlling insects, weeds and diseases that combines regular monitoring, preventive practices (like crop rotation and habitat management), use of natural predators, and targeted, minimal use of pesticides only when needed. For investors it matters because IPM can lower long‑term input costs, reduce regulatory and reputational risk, improve crop yields and supply stability, and signal more sustainable operations—like doing routine maintenance on a building to avoid expensive emergency repairs.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Revenue increased 42% sequentially as e-commerce and subscriptions expanded; 

Gross profit reached a record $796,000

SURPRISE, Ariz., Nov. 10, 2026 (GLOBE NEWSWIRE) -- SenesTech, Inc. (NASDAQ: SNES), an innovator in rodent control, today announced financial results for the third quarter ended September 30, 2026.

Q3 2026 Financial Highlights

• Total revenue increased 42% sequentially to a record $1.097 million in Q3 2026, compared to $770,000 in Q2 2026, and increased 59% compared to $690,000 in Q3 2025. This was the second consecutive quarterly revenue record and the first quarter above $1 million, consistent with the preliminary revenue of approximately $1.1 million announced on October 15, 2026.
• E-commerce revenue increased 52% sequentially and 337% year over year, representing approximately 71% of total Q3 revenue.
• Subscription revenue increased 53% sequentially and 234% year over year. Combined subscribers across Amazon and the Company’s website increased 72% compared to Q2 2026, strengthening the recurring revenue base.
• Direct B2B revenue increased 19% sequentially and 2% year over year. Sequential growth was driven by process changes to the Company’s B2B efforts, which drove growth in the pest management, government and commercial verticals.
• Evolve® revenue increased 67% year over year to $979,000 and represented 89% of product revenue. ContraPest® revenue increased 13% year over year to $118,000, driven by higher refill sales.
• Gross profit increased 40% to a record $796,000 in Q3 2026, compared to $567,000 in Q2 2026, and increased 84% compared to $433,000 in Q3 2025.
• Gross margin was 72.6% in Q3 2026, compared to 73.6% in Q2 2026 and 62.8% in Q3 2025.
• Net loss for Q3 2026 was $2.0 million, compared to $1.8 million in Q2 2026 and $1.3 million in Q3 2025.
• Adjusted EBITDA loss was $1.4 million in Q3 2026, compared to $1.4 million in Q2 2026 and $1.1 million in Q3 2025.
• Cash and cash equivalents at the end of the quarter were $4.0 million. Subsequent to the end of the quarter, the Company raised $1.2 million in gross proceeds from the ATM.
  
• Net cash used in operating activities declined each quarter in 2026, falling to $1.3 million in Q3 from $1.7 million in Q2 2026 and $1.9 million in Q1 2026.
  

Recent Operational and Strategic Highlights

• Amazon Revenue and Subscriptions Continue to Grow: Amazon revenue increased each month of Q3, bringing in new customers and expanding the recurring subscription base.
• B2B Sales Team Expanded: The Company added two salespeople, bringing the team under Executive Vice President of Sales Jack Karabees to four, with two additional hires expected by year end. The team is focused on building repeat business across targeted domestic verticals.
• E-commerce Reach Expanded Through Grove Collaborative: SenesTech added Grove Collaborative as a third-party e-commerce channel, bringing Evolve® to an engaged base of consumers focused on sustainability.
• Assessment and Monitoring Services Launched for B2B Customers: In July, SenesTech began offering assessment services to help B2B customers measure rodent activity and understand the scope of an infestation. Customers can choose an assessment performed by SenesTech or deploy the Company’s tracking products themselves, with results analyzed using SenesTech’s internally developed AI tool. These services complement existing implementation and deployment services and are expected to provide an additional revenue opportunity.
• Municipal Results Support Broader Adoption: Chicago’s Wicker Park Bucktown program, which incorporated SenesTech’s assessment services and Evolve® into an integrated pest management approach, reduced average rat activity intensity by 88% over 12 months. Evolve has expanded to six Chicago-area Special Service Areas and wards. In Swampscott, Massachusetts, Evolve Rat, combined with sanitation and waste management improvements, helped reduce measured rodent activity by 43% over six months.
• Sandstrom Partners Engaged to Support Branding and Marketing: SenesTech engaged Sandstrom Partners, a Portland, Oregon, brand development firm whose clients have included Nike, Target and Coca-Cola, as a strategic advisor on marketing and branding. An early priority is helping retain Amazon customers and attract new customers by more clearly communicating how the Company’s rodent birth control products work.

Management Commentary

“SenesTech delivered a milestone third quarter, exceeding $1 million in quarterly revenue for the first time and setting new records for revenue, gross profit and subscription customers,” said Michael Edell, President and Chief Executive Officer of SenesTech. “These results demonstrate the momentum we are building. With e-commerce delivering strong growth and our expanded B2B sales team pursuing new opportunities, we are excited about the foundation we are establishing for continued growth.

“Our e-commerce business continues to lead the way, with revenue increasing 52% sequentially, driven by another record quarter on Amazon. Across Amazon and our website, combined subscription customers increased 72% sequentially, while subscription revenue grew 53%. We are reaching more customers and building ongoing relationships that support repeat purchases, greater revenue visibility and long-term customer value.

“We see direct B2B as the next significant driver of growth alongside our expanding e-commerce business. By expanding the sales team, we have increased our capacity to pursue opportunities across our targeted verticals. Direct B2B revenue increased 19% sequentially, and we believe our growing brand awareness, broader customer adoption and focused sales efforts position us to build on that progress,” Mr. Edell concluded.

“Record gross profit of $796,000 and a gross margin of 72.6% highlight the strength of our business model as revenue scales,” said Tom Chesterman, Chief Financial Officer of SenesTech. “Our focus is on translating this commercial momentum into sustained financial progress. We are also putting our cash to work more efficiently: excluding non-cash items such as stock-based and other non-cash compensation, depreciation and straight-line rent, sales and marketing has grown as a share of operating expenses compared to the third quarter of 2025, while general and administrative spending has declined as a share.”

Use of Non-GAAP Measures

Adjusted EBITDA is a non-GAAP measure and is not intended to be a substitute for those financial measures reported in accordance with GAAP. This measure has been included because management believes that, when considered together with the GAAP figures, it provides meaningful information related to operating performance and liquidity trends. We use these non-GAAP financial measures as part of our overall assessment of our performance, including the preparation of our annual operating budget and quarterly forecasts, to evaluate the effectiveness of our business strategies, and to communicate with our board of directors concerning our financial performance. These adjustments may be calculated by us differently than other companies that disclose measures with the same or similar terms. See our attached financials for a reconciliation of the non-GAAP measures to the nearest GAAP measure.

Conference Call Details

Date: Tuesday, November 10, 2026.

Time: 5 p.m. ET.

Call-in Information: Interested parties can access the live teleconference by dialing 1-844-308-3351 or 1-412-317-5407.

Webcast: https://app.webinar.net/EM53kOPaJDx

Webcast Replay: Available for 90 days on the Company’s website.

About SenesTech

SenesTech is the leader in rodent birth control and sustainable rodent population management, with a mission to support a healthier environment through the responsible management of animal pest populations. The Company’s Evolve® and ContraPest® fertility control solutions, along with its assessment and monitoring services, target reproduction to help reduce rodent populations. SenesTech serves consumer and professional markets with proven approaches that can be used independently or as part of an integrated pest management (IPM) program.

For more information, visit https://senestech.com/.

Safe Harbor Statement

This press release contains “forward-looking statements” within the meaning of federal securities laws, and we intend that such forward-looking statements be subject to the safe harbor created thereby. Such forward-looking statements include, without limitation, statements regarding expected growth in e-commerce, subscription and direct B2B revenue; the planned addition of two salespeople by year end; the anticipated benefits of the Company’s third-party e-commerce relationship with Grove Collaborative; the expansion of municipal adoption of Evolve®; the anticipated benefits of, and revenue opportunity from, the Company’s assessment services; the anticipated benefits of the Company’s engagement of Sandstrom Partners, including improved customer retention and acquisition; and the Company’s ability to use cash more efficiently.

Forward-looking statements may describe future expectations, plans, results or strategies and are often, but not always, made through the use of words such as “believe,” “may,” “future,” “plan,” “will,” “should,” “expect,” “anticipate,” “eventually,” “project,” “estimate,” “continuing,” “intend” and similar words or phrases. You are cautioned that such statements are subject to risks, uncertainties and other factors that could cause actual results to differ materially from those reflected by such forward-looking statements. Such factors include, among others, the Company’s ability to sustain revenue growth across its e-commerce and B2B channels; its reliance on Amazon and other third-party platforms; its ability to retain and grow subscribers; the ability of its sales team to generate direct B2B revenue; the continued adoption of its products by municipalities; market acceptance of its assessment services and its ability to deliver them profitably; the effectiveness of its marketing and branding initiatives; the Company’s history of losses and need for additional capital to fund operations; its ability to manage operating expenses and cash; competition; regulatory developments affecting its products, including EPA and state registration requirements; supply chain and manufacturing risks; general economic conditions; and other factors and risks identified from time to time in our filings with the Securities and Exchange Commission, including the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2025. All forward-looking statements contained in this press release speak only as of the date on which they were made and are based on management’s assumptions and estimates as of such date. Except as required by law, we do not undertake any obligation to publicly update any forward-looking statements, whether as a result of the receipt of new information, the occurrence of future events or otherwise.

CONTACT:

Investors: Robert Blum, Lytham Partners, LLC, (602) 889-9700, senestech@lythampartners.com

Company: Tom Chesterman, Chief Financial Officer, SenesTech, Inc., (928) 779-4143

SENESTECH, INC. BALANCE SHEETS (In thousands, except share and per share data) (Unaudited)
	September 30, 2026				December 31, 2025
ASSETS
Current assets:
Cash and cash equivalents	$	3,951			$	7,575
Short-term investments		—				994
Accounts receivable, net		247				201
Inventory		966				994
Prepaid expenses and other current assets		398				297
Total current assets		5,562				10,061
Right to use asset, operating lease		2,211				2,336
Property and equipment, net		334				410
Other noncurrent assets		36				36
Total assets	$	8,143			$	12,843
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable	$	357			$	183
Accrued expenses		615				383
Current portion of operating lease liability		151				139
Current portion of notes payable		65				61
Deferred revenue		45				32
Total current liabilities		1,233				798
Operating lease liability, less current portion		2,217				2,332
Notes payable, less current portion		95				145
Total liabilities		3,545				3,275
Stockholders’ equity:
Common stock		5				5
Additional paid-in capital		152,924				152,043
Accumulated deficit		(148,331	)			(142,480	)
Total stockholders’ equity		4,598				9,568
Total liabilities and stockholders’ equity	$	8,143			$	12,843

SENESTECH, INC. STATEMENTS OF OPERATIONS (In thousands, except share and per share data) (Unaudited)
	Three Months Ended September 30,								Nine Months Ended September 30,
	2026				2025				2026				2025
Revenues, net	$	1,097			$	690			$	2,360			$	1,800
Cost of sales		301				257				659				645
Gross profit		796				433				1,701				1,155
Operating expenses:
Research and development		418				400				1,217				1,245
Sales and marketing		1,082				425				2,218				1,277
General and administrative		1,287				955				4,238				3,257
Total operating expenses		2,787				1,780				7,673				5,779
Loss from operations		(1,991	)			(1,347	)			(5,972	)			(4,624	)
Interest income, net		35				49				121				45
Net loss	$	(1,956	)		$	(1,298	)		$	(5,851	)		$	(4,579	)
Weighted average shares outstanding — basic and diluted		5,420,899				4,668,009				5,329,923				2,619,841
Loss per share — basic and diluted	$	(0.36	)		$	(0.28	)		$	(1.10	)		$	(1.75	)

SENESTECH, INC. STATEMENTS OF CASH FLOWS (In thousands) (Unaudited)
	Three Months Ended September 30,								Nine Months Ended September 30,
	2026				2025				2026				2025
Cash flows from operating activities:
Net loss	$	(1,956	)		$	(1,298	)		$	(5,851	)		$	(4,579	)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation		276				47				481				228
Depreciation and amortization		32				29				94				103
Other non-cash expenses, net		7				43				16				87
Changes in operating assets and liabilities, net		319				(200	)			300				75
Net cash used in operating activities		(1,322	)			(1,379	)			(4,960	)			(4,086	)
Cash flows from investing activities:
Purchase of held-to-maturity investments		—				(2,964	)			—				(2,964	)
Maturity of held-to-maturity investment		—				—				1,000				—
Purchase of property and equipment		(18	)			(42	)			(18	)			(125	)
Net cash provided by (used in) investing activities		(18	)			(3,006	)			982				(3,089	)
Cash flows from financing activities:
Proceeds from the exercise of warrants, net		—				5,622				—				10,482
Proceeds from issuances of common stock, net		227				—				400				2,706
Repayments of notes payable		(16	)			(14	)			(46	)			(42	)
Net cash provided by financing activities		211				5,608				354				13,146
Increase (decrease) in cash and cash equivalents		(1,129	)			1,223				(3,624	)			5,971
Cash and cash equivalents, beginning of period		5,080				6,055				7,575				1,307
Cash and cash equivalents, end of period	$	3,951			$	7,278			$	3,951			$	7,278

SENESTECH, INC. Itemized Reconciliation Between Net Loss and Adjusted EBITDA (non-GAAP) (In thousands) (Unaudited)
	Three Months Ended September 30,								Nine Months Ended September 30,
	2026				2025				2026				2025
Net loss (as reported, GAAP)	$	(1,956	)		$	(1,298	)		$	(5,851	)		$	(4,579	)
Non-GAAP adjustments:
Stock-based and non-cash compensation		524				18				757				299
Severance costs		—				—				503				27
One-time legal costs		—				111				217				356
Interest income, net		(35	)			(49	)			(121	)			(45	)
Depreciation expense		32				29				94				103
Non-cash operating lease expense		7				49				22				87
Total non-GAAP adjustments		528				158				1,472				827
Adjusted EBITDA loss (non-GAAP)	$	(1,428	)		$	(1,140	)		$	(4,379	)		$	(3,752	)

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How much did SenesTech's revenue grow in Q3 2026?

SenesTech's Q3 2026 revenue increased 59% year over year and 42% sequentially to $1.097 million. This was its second consecutive quarterly revenue record and its first quarter above $1 million.

Was SenesTech profitable in Q3 2026?

SenesTech reported a net loss of $1.956 million, or $0.36 per share, in Q3 2026. That compares with a net loss of $1.298 million, or $0.28 per share, a year earlier.

How do SenesTech's new B2B assessment services work?

B2B customers can choose a SenesTech-performed assessment or deploy the company's tracking products themselves. Results are analyzed using SenesTech's internally developed artificial intelligence tool to help customers measure rodent activity and understand the scope of an infestation.